HC Wainwright Reaffirms Buy Rating for Vir Biotechnology (NASDAQ:VIR)
HC Wainwright reiterated their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. HC Wainwright currently has a $110.00 target price on the stock. Several other research firms have also issued reports on VIR. Barclays lowered their target price on shares of […]
More Stories
Activest Wealth Management Boosts Stock Holdings in Super Micro Computer, Inc. (NASDAQ:SMCI)
Activest Wealth Management raised its stake in shares of Super Micro Computer, Inc. (NASDAQ:SMCI – Free Report) by 78.9% in...
Activest Wealth Management Acquires 215 Shares of Simon Property Group, Inc. (NYSE:SPG)
Activest Wealth Management raised its holdings in shares of Simon Property Group, Inc. (NYSE:SPG – Free Report) by 20.0% in...
Banco Santander, S.A. (NYSE:SAN) Shares Sold by Activest Wealth Management
Activest Wealth Management cut its stake in Banco Santander, S.A. (NYSE:SAN – Free Report) by 24.8% in the third quarter,...
PGIM High Yield Bond Fund, Inc. (NYSE:ISD) Shares Bought by Activest Wealth Management
Activest Wealth Management increased its stake in shares of PGIM High Yield Bond Fund, Inc. (NYSE:ISD – Free Report) by...
Activest Wealth Management Decreases Position in Capricor Therapeutics Inc (NASDAQ:CAPR)
Activest Wealth Management trimmed its holdings in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) by 50.0% in the...
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Position in Ecolab Inc. (NYSE:ECL)
BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in shares of Ecolab Inc. (NYSE:ECL – Free Report) by 25.3%...